News

Engrain Enhances Utility Cost Transparency with Billee

Engrain Enhances Utility Cost Transparency with Billee

Engrain Partners with Billee for Enhanced Utility Cost Precision

Engrain, a leader in interactive touring and data visualization software, has announced an exciting new initiative. The company plans to integrate with Billee, a cutting-edge utility billing platform designed specifically for the multifamily housing sector. This collaboration aims to enhance the accuracy of utility cost calculations accessible through Engrain's innovative fee calculator, found in their SightMap product.

Improving Renters' Experiences with Reliable Billing Data

Currently, renters often encounter estimated utility charges, or in some cases, no utility information during their apartment to rent search. The partnership with Billee will allow Engrain to provide property-specific utility data, transitioning from general estimates to precise utility cost quotations tailored for residents. This improvement includes detailed information on various utilities, such as water, gas, and electricity, which will result in a more transparent renting experience.

Commitment to Transparency for Multifamily Operators

Brent Steiner, the founder and CEO of Engrain, emphasizes the importance of transparency, stating, "Fee transparency is no longer optional for multifamily operators." The upcoming integration reflects a shared vision to deliver accurate pricing to renters while enabling operators to modernize how they present and manage utility cost information.

Modern Utility Billing Solutions for Multifamily Housing

Billee Technologies offers a full suite of utilities billing services that seamlessly blend their multifamily expertise with a modern technology framework. The integration of Billee’s data with Engrain’s intuitive fee calculator will allow property operators to provide a complete and transparent overview of housing costs throughout the entire leasing process.

Creating Trust with Real Data

John Hinckley, CEO of Billee, shares his insights: "Renters expect clarity, and operators need systems that can actually deliver it." By combining Billee's detailed utility information at the unit level with Engrain’s robust visualization tools, both companies aim to replace vague estimates with accurate, trustworthy data, thereby enhancing the overall renter experience and offering a scalable model for operators.

Expected Launch and Initial Testing

The integration between Engrain and Billee is projected to be launched in the first quarter of 2026, with an initial testing phase set to occur at a select number of multifamily properties. This testing will serve to refine and optimize the integration before broader implementation.

About Engrain

Engrain's mission centers around transforming how people find, lease, and manage properties. As a leader in interactive touring and mapping technology, Engrain’s advanced integrations and flexibility cater to diverse multifamily technology needs. Clients leverage Engrain’s products to enhance tenant engagement, streamline operations, and boost net operating income through improved efficiency in property management.

About Billee

Billee Technologies stands at the forefront of utility billing innovation for property owners. They are committed to transforming utility management through intelligent automation and data access. Aiming to enhance net operating income and improve process efficiency for multifamily operators, Billee's platform harnesses the power of automation and machine learning. Their centralized system provides intelligent recommendations, significantly reducing the administrative burden associated with utility billing.

Frequently Asked Questions

What is the purpose of Engrain's integration with Billee?

The integration aims to provide precise utility cost estimates to renters, enhancing transparency in multifamily housing.

When is the expected launch date for the integration?

The integration is expected to launch in the first quarter of 2026.

Who are the key executives involved in this partnership?

Brent Steiner, CEO of Engrain, and John Hinckley, CEO of Billee, are leading this initiative.

What benefits will renters see from this integration?

Renters will receive more accurate utility cost estimates, leading to a clearer understanding of their total monthly living expenses.

What does Engrain specialize in?

Engrain specializes in interactive touring, mapping, and data visualization software tailored for the multifamily housing market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Coca-Cola's Recent Unusual Options Trends

Updated Category News Views 259

Analyzing Coca-Cola's Recent Options Activity Investors are showing a bearish trend toward Coca-Cola (KO), which is an important indicator for retail traders monitoring investment trends. The recent unusual options activity suggests that these investors may possess insights not yet shared with the public. Thus, individual traders should be particularly attentive to these...

Continue Reading
Sustainable Palm Oil Market Growth Driven by AI Insights

Updated Category News Views 136

Exploring the Growth of the Sustainable Palm Oil Market The sustainable palm oil market is currently on the rise, fueled by a growing demand for trans-fat-free products and innovations in eco-friendly farming practices. This growth is expected to hit around USD 2.75 billion by 2028, reflecting a solid compound annual growth rate (CAGR) of about 5.24% in the coming years....

Continue Reading
Grilling Safety Tips from Ferrellgas This Labor Day

Updated Category News Views 82

Grilling Safety Tips from Ferrellgas This Labor Day As we gear up for one of the biggest grilling holidays of the year, it's essential to keep safety in mind while savoring delicious meals with family and friends. Ferrellgas Partners, L.P. is taking this opportunity to remind customers about the significance of safe grilling practices this Labor Day. This holiday not only...

Continue Reading
Solstice Gold Secures Funding Through Successful Placement Deal

Updated Category News Views 127

Solstice Gold Completes Successful Private Placement Financing Solstice Gold Corp. (“Solstice”, “we”, “our”, or the “Company”) is thrilled to announce the successful closing of its private placement financing. This significant financial milestone comes with gross proceeds of approximately $150,000 from the issuance of 6,600,000 shares. This private...

Continue Reading
Avanos Medical Introduces Innovative CORGRIP SR System

Updated Category News Views 32

Avanos Medical Launches New CORGRIP SR Advancement to reduce dislodgement in feeding tube retention systems Avanos Medical, Inc. (NYSE: AVNS) recently announced an exciting development in its Enteral Feeding portfolio with the launch of the CORGRIP SR Nasogastric/Nasointestinal Tube Retention System. This innovative design aims to provide enhanced support and security for...

Continue Reading